Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Delayed Xetra 12:35:13 2024-03-28 pm EDT 5-day change 1st Jan Change
163.6 EUR +2.12% Intraday chart for Merck KGaA +1.24% +13.53%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
UBS Raises Merck KGaA PT, Keeps Buy Rating MT
MERCK KGAA : Jefferies keeps its Buy rating ZD
MERCK KGAA : price target raised by UBS CF
MERCK KGAA : Buy rating from UBS ZD
Merck KGaA to Open $326 Million Pharmaceutical Plant in South Korea to Expand in Asia DJ
Merck KGaA Spends EUR300 Million on New Bioprocessing Site in South Korea MT
MERCK KGAA : DZ Bank gives a Buy rating ZD
MERCK KGAA : JP Morgan gives a Buy rating ZD
MERCK KGAA : Barclays gives a Buy rating ZD
Deutsche Bank raises target for Merck KGaA to 175 euros - 'Buy' DP
MERCK KGAA : Deutsche Bank remains its Buy rating ZD
MERCK : A weak finish but the 2024 guidance leaves room for positives Alphavalue
MERCK KGAA : Deutsche Bank reiterates its Buy rating ZD
German Equities Rise as ECB Opens Up to Rate Cuts MT
Global markets live: Darktrace, Merck, Meta, Apple, Eli Lilly... Our Logo
MERCK KGAA : Jefferies remains its Buy rating ZD
Merck KGaA Provides Earnings Guidance for the Year 2024 CI
Merck KGaA Proposes Dividend for the Year 2023 CI
Transcript : MERCK Kommanditgesellschaft auf Aktien, Q4 2023 Earnings Call, Mar 07, 2024
MERCK KGAA : Buy rating from Barclays ZD
MERCK KGAA : UBS reaffirms its Buy rating ZD
Merck KGaA Reports Decline in FY23 Attributable Profit, Net Sales MT
European Midday Briefing : ECB Expected to Hold Rates, Lagarde Message Key DJ
Merck KGaA: aims to return to organic growth in 2024 CF
Dpa-AFX Overview: COMPANIES from 07/03/2024 - 10:15 am DP
Chart Merck KGaA
More charts
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
163.6 EUR
Average target price
181.1 EUR
Spread / Average Target
+10.68%
Consensus
  1. Stock
  2. Equities
  3. Stock Merck KGaA - Xetra
  4. News Merck KGaA
  5. MERCK Kommanditgesellschaft auf Aktien : KGaA Appoints China, International Markets' Health Head